A Phase II Trial of PULSAR (Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy) Combined With PD-1 Ab and Chemotherapy Plus Bevacizumab for Colorectal Cancer Liver Metastasis
Latest Information Update: 31 Jan 2025
Price :
$35 *
At a glance
- Drugs Bevacizumab (Primary) ; Sintilimab (Primary) ; Capecitabine; Oxaliplatin
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 31 Jan 2025 New trial record